Doppler Ultrasound as a Unique Diagnosis Test in Peripheral Arterial Disease

Rivera, Elena García; Cenizo-Revuelta, N.; Ibáñez-Maraña, María Antonia; Domingos, Liliana Fidalgo; Estévez-Fernández, Isabel; Flota-Ruiz, Cintia; Norberto, Enrique M. San; Vaquero-Puerta, Carlos

doi:10.1016/j.avsg.2020.10.027

Cited by 7 publications

(5 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is no unified DUS diagnostic standard for PAD so far. Most studies measure the peak systolic velocity (PSV) of lower-extremity artery segments through the doppler spectrum, and PAD can be diagnosed when the PSV at the stenosis is ≥ 200 cm/s or the PSV ratio ≥ 2 at the stenosis to the proximal [ 36 , 37 ]. A reduction of arterial lumen diameter ≥ 50% measured by B-mode ultrasound could also be taken as a diagnostic standard [ 30 ].…”

Section: Early Screening Methods For Pad In Icvd Patientsmentioning

confidence: 99%

Early identification and treatment for peripheral arterial disease in patients with ischemic cerebrovascular disease

2023

Eur J Med Res

View full text Add to dashboard Cite

Ischemic cerebrovascular disease (ICVD) is a major cause of mortality and disability worldwide and is often caused by atherosclerosis. As a systemic disease, atherosclerosis usually affects multiple vascular beds, mainly including cerebral, coronary, and peripheral arteries. Therefore, ICVD is easily complicated by lower-extremity peripheral arterial disease (PAD). ICVD patients with PAD have more serious symptoms and a worse prognosis, however, neurologists might neglect the evaluation and management of the coexistent PAD, and there is still a lack of consensuses about the diagnosis and treatment for such patients. By summarizing relevant research progresses, this review showed that duplex ultrasound had more advantages in the early screening and evaluation of PAD in ICVD patients among multiple methods to diagnose PAD. Furthermore, the current evidence seems to support that single-drug antiplatelet can be used as the basic treatment, and new antithrombotic strategies, such as ticagrelor only or aspirin combined with low-dose rivaroxaban are expected to further reduce the incidence of stroke for ICVD patients with PAD. More effective treatments would be explored by large-scale trials to guide the clinical management to prevent secondary stroke for such patients.

show abstract

Section: Early Screening Methods For Pad In Icvd Patientsmentioning

confidence: 99%

Early identification and treatment for peripheral arterial disease in patients with ischemic cerebrovascular disease

2023

Eur J Med Res

View full text Add to dashboard Cite

show abstract

“… 11 Additionally, many centers use DUS for arterial assessment and for planning treatment in peripheral occlusive disease, but there are few references in the literature reporting validation of the method. One study of relevance to the issue was published in 2021 by García-Rivera et al, 14 demonstrating that DUS had 80% sensitivity and 95.45% specificity in femoropopliteal lesions when compared with intraoperative angiography. These results suggest that DUS could merit consideration as the only preoperative imaging exam for surgical planning in patients scheduled for lower limb revascularization procedures.…”

Section: Introductionmentioning

confidence: 99%

“…Além disso, vários centros utilizam a EVD para avaliação arterial e planejamento do tratamento na doença oclusiva periférica, mas há poucas referências para a validação do método na literatura. Um estudo relevante na área, publicado em 2021 por García-Rivera et al 14 , demonstrou uma sensibilidade de 80% e especificidade de 95,45% em lesões fêmoro-poplíteas para a EVD em comparação com a angiografia intraoperatória. Os resultados sugerem que a EVD pode ser considerada como um exame de imagem pré-operatório único durante o planejamento cirúrgico em pacientes submetidos a um procedimento de revascularização de membros inferiores.…”

Section: Introductionunclassified

Comparison between vascular Doppler ultrasound and contrast exams in chronic peripheral arterial disease

Cantador,

Guillaumon

2024

J. vasc. bras.

View full text Add to dashboard Cite

Background Vascular Doppler ultrasound (DUS) has evolved over recent years because of improvements in the technology involved in the acquisition and processing of sound and image data. The method is an excellent option for use in diagnosis of peripheral arterial disease considering its availability, low cost, and absence of harmful effects. The breakdown of logistics supply chains caused by the COVID-19 pandemic caused worldwide shortages of iodinated contrast, highlighting the need to validate alternative diagnostic methods. Objective To use DUS for decision-making when choosing between by-pass and endovascular surgery for femoropopliteal arterial disease and compare the results to those of iodinated contrast exams. Methods We compared DUS with examinations using contrast for identification of stenoses/occlusions and indication of surgical treatment (by-pass vs. endovascular). In the first phase of the study the results were merely compared, DUS vs. angiotomography. Then, in the second phase, the vascular ultrasound results were used for screening between by-pass and endovascular treatment, comparing DUS with angiotomography in cases scheduled for by-pass and with arteriography in endovascular patients. Results In phase 1, the sensitivity of DUS compared to CT angiography was 100% for the SFA territory. When considering solely the choice of bypass vs. endovascular treatment, the results showed 100% agreement for phase 1 and 94% for phase 2. Conclusion Notwithstanding the sample size, the study fulfilled its objective of demonstrating the reliability of DUS for indicating the treatment choice between by-pass and endovascular surgery.

show abstract

“…Several diagnostic techniques, including Doppler ultrasonography [7], magnetic resonance angiography (MRA) [8], and computed tomography angiography (CTA), were employed to identify peripheral vascular disease [9]. In the majority of PVD cases, atherosclerotic plaques reduce the arterial flow lumen, restricting blood flow to the distal extremity.…”

Section: Introductionmentioning

confidence: 99%

A Combined Treatment Effect of Cilostazol and Pentoxifylline in the Treatment of Peripheral Vascular Disease

Suthar

Shah²,

Ranjan

2022

AJMAH

View full text Add to dashboard Cite

Background: (50 mg BD) and pentoxifylline (400 mg TDS) therapy in patients with PVD. Additionally, the adverse effects and economic burden of the combination was taken in to account. Methodology: An Observational antegrade study was done among 100 patients. A Patient with PVD visited to OPD of the vascular department was enrolled in the study. Data was collected as per the Case Record Form. Results: The mean age was found to be 58.4 ± 11.3 years of total 100 patients. An improvement in a Doppler testing (follow-up at the time interval after 1 month, 3 months and 6 months) and increased in peak systolic velocity in distal vessels as well as collaterals were observed in all patients. The PVD was prevalent in 50 to 60 years of age groups and hypertension and smoking were the most common risk factors present in PVD patients. There was more than 70% increase in walking distance after 24 weeks of treatment. Headache 24 (36.4%) and Dizziness 9 (13.6%) were observed as common side effect of therapy. The total cost of the combination therapy was affordable with improved quality of life. Conclusion: The combination treatment showed symptomatic improvement in peripheral vascular disease in the study. The peak systolic velocity gradually increased in the distal vessel and the combination was found to be cost-effective.

show abstract

Doppler Ultrasound as a Unique Diagnosis Test in Peripheral Arterial Disease

Cited by 7 publications

References 23 publications

Early identification and treatment for peripheral arterial disease in patients with ischemic cerebrovascular disease

Early identification and treatment for peripheral arterial disease in patients with ischemic cerebrovascular disease

Comparison between vascular Doppler ultrasound and contrast exams in chronic peripheral arterial disease

A Combined Treatment Effect of Cilostazol and Pentoxifylline in the Treatment of Peripheral Vascular Disease

Contact Info

Product

Resources

About